Skip to main content
Earnings Labs
Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc. (SUPN) Earnings

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic

$40.85

—

Mkt Cap $2.37B

EPS — Estimate vs Actual

Mkt Cap

$2.37B

P/E

—

Fwd P/E

25.99

P/S

3.05

Rev TTM

—

EPS TTM

-$0.51